Verrica Pharmaceuticals buy Needham & Company LLC
Start price
23.08.23
/
50%
€3.90
Target price
23.08.24
€9.25
Performance (%)
77.44%
Price
25.07.24
€6.69
Summary
This prediction is currently active. With a performance of 77.44% the BUY prediction by Needham___Company_LL is a big success. This prediction currently runs until 23.08.24. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Verrica Pharmaceuticals | -4.126% | -4.126% |
iShares Core DAX® | 0.039% | 0.567% |
iShares Nasdaq 100 | -4.018% | -5.554% |
iShares Nikkei 225® | -2.389% | -1.434% |
iShares S&P 500 | -2.115% | -2.351% |
Comments by Needham___Company_LL for this prediction
In the thread Discuss Verrica Pharmaceuticals
Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $10.00 price target on the stock.
Ratings data for VRCA provided by MarketBeat
Stopped prediction by Needham___Company_LL for Verrica Pharmaceuticals
Verrica Pharmaceuticals
Start price
Target price
Perf. (%)
€9.90
14.05.24
14.05.24
€14.81
14.05.25
14.05.25
-30.10%
25.07.24
25.07.24
Verrica Pharmaceuticals
Start price
Target price
Perf. (%)
€2.74
10.11.23
10.11.23
€7.49
10.11.24
10.11.24
134.67%
25.07.24
25.07.24